Boundless Bio (United States)
company in San Diego, United States
BOLD Nasdaq
SEC CIK 1782303
Follow Boundless Bio (United States)
Weekly email: filings, results
Net income
−$5.4M
+61.4% vs same quarter last year
EPS, diluted
−$0.23
+62.9% vs same quarter last year
Operating cash flow
−$10.9M
−6.7% vs same quarter last year
Operating income
−$6.2M
+59.1% vs same quarter last year
Source: SEC XBRL filings · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY25 | −$58.2M |
| FY24 | −$65.4M |
| FY23 | −$49.4M |
| FY22 | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$47.2M |
| FY24 | −$63.4M |
| FY23 | −$47.5M |
| FY22 | - |